Competent Cells Market Worth 2.22 Billion USD by 2022

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 101 Market Data Tables and 39 Figures spread through 159 Pages and in-depth TOC on "Competent Cells Market"

http://www.marketsandmarkets.com/Market-Reports/competent-cells-market-265815900.html
Early buyers will receive 10% customization on this report

By type, the chemically competent cells segment is expected to dominate the market in 2017 

Based on the type of competent cells, the market is segmented into chemically competent cells and electro competent cells. The growth of the chemically competent cells segment can be attributed to the rising intensity of research (due to technological advancement) and availability of government support, along with the growing market demand for molecular cloned products.

By application, the cloning segment is expected to dominate the market in 2017 

Based on application, the Competent Cells Market is broadly segmented into cloning, protein expression, and other applications. Cloning is expected to command the largest share of this market in 2017. Increasing research on cloning, driven by government support and funding is among the major factors driving market growth in this segment.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=265815900

The cloning application is further segmented into subcloning & routine cloning, phage display library construction, toxic/unstable DNA cloning, and high-throughput cloning. Similarly, other applications of competent cells include mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation.

By end user, the academic research institutes segment is expected to dominate the market in 2017 

On the basis of end user, the Competent Cells Market is segmented into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. In 2017, the academic research institutes segment is expected to account for the largest share of the market. The growth of this end-user segment is driven by the increase in research funding for life science projects worldwide.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=265815900

North America to dominate the Competent Cells Market in 2017 

By region, the global Competent Cells Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America is expected to account for the largest share of the market. This can be attributed to the increasing intensity of research due to technological advancement and increasing commercial needs for genomic and protein expressed products, in North American countries.

Key players operating in the Competent Cells Market include Merck KGaA (Germany), Promega Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics, LLC (U.S.), and Yeastern Biotech Co., Ltd. (Taiwan).

Browse Related Reports 

Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User - Global Forecast to 2022.

http://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html

Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers) - Trends & Global Forecasts to 2021.

http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets' flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets